46887615_2_Diabetes_Therapy_if_Approved__5
[0] GLP-1 agonist [1] Byetta, Bydureon, Victoza [2] Stimulates the receptor in the pancreas that releases post prandial insulin [3] More potent than some other drugs in reduction of blood sugar, weight loss sometimes noted [4] Injectable, Expensive [5] 
Gaining favor for patients with primarily post prandial hyperglycemia who need weight loss
Where Will Invokana (canagliflozin) Fit in Type 2 Diabetes Therapy if Approved
5